Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity
Seda Yılmaz
1
,
İklimya Nimet Ataş
1
Elazığ Fethi Sekin City Hospital, Elazığ, Turkey
Neuropsychiatria i Neuropsychologia 2025; 20, 3–4: 117–124
Yılmaz S, Ataş İN. Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2025;20(3):117-124. doi:10.5114/nan.2025.158840.
APA
Yılmaz, S., & Ataş, İ. N. (2025). Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, 20(3), 117-124. https://doi.org/10.5114/nan.2025.158840
Chicago
Yılmaz, Seda, and İklimya N Ataş. 2025. "Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity". Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology 20 (3): 117-124. doi:10.5114/nan.2025.158840.
Harvard
Yılmaz, S., and Ataş, İ. (2025). Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, 20(3), pp.117-124. https://doi.org/10.5114/nan.2025.158840
MLA
Yılmaz, Seda et al. "Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity." Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology, vol. 20, no. 3, 2025, pp. 117-124. doi:10.5114/nan.2025.158840.
Vancouver
Yılmaz S, Ataş İ. Elevated serum homocysteine levels and cognitive impairment in methamphetamine use disorder: the impact of attention deficit hyperactivity disorder comorbidity. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology. 2025;20(3):117-124. doi:10.5114/nan.2025.158840.
